NetworkNewsBreaks – Annovis Bio Inc. (NYSE: ANVS
Post# of 124

Annovis Bio (NYSE: ANVS) will host a live webcast on Feb. 27, 2025, at 4:30 p.m. EST, where CEO Maria Maccecchini, Ph.D., will answer questions from patients, caregivers, and families regarding the company’s clinical trials and future plans. The forum will provide updates on the ongoing Phase 3 Alzheimer’s disease trial, plans for the Phase 3 Parkinson’s disease study, and patient communication strategies. A brief presentation will precede a Q&A session, with attendees encouraged to submit questions in advance. The event underscores Annovis’ commitment to patient engagement and transparency.
NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://nnw.fm/ANVS
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

